Showing results (1621-1630 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 1, 1991
Evaluation of BRL 42715, a beta-lactamase-inhibiting penemS M Qadri, Y Ueno, M Burdette, et al.Chemotherapy|January 1, 1991
Virulence of clinical and fecal isolates of Clostridium perfringens type A for outbred NMRI miceW H Traub, D Bauer, U WolfChemotherapy|July 26, 2006
Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal functionNaoyuki Tajima, Hitoshi Ishizuka, Hideo NaganumaChemotherapy|January 1, 1991
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamilF V Donenko, T Efferth, J Mattern, et al.Chemotherapy|September 30, 2006
Autoimmune cholangitis presented as fever of unknown originConstantinos Petrogiannopoulos, Konstantinos Papamichael, Georgios Karachalios, et al.Chemotherapy|May 15, 2007
Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?Arne Schäfer, Michael Scheurlen, Benedikt Weissbrich, et al.Chemotherapy|January 1, 1988
Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancersG Beskid, J Unowsky, C R Behl, et al.Chemotherapy|May 9, 2021
Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 PatientsSamuel Pecho-Silva, Ana Claudia Navarro-Solsol, Vicky Panduro-Correa, et al.Chemotherapy|January 1, 1985
Trends in bacterial susceptibility to antimicrobial agentsM M Lane, D E Parker, D J FlournoyChemotherapy|April 29, 1998
In vitro antibacterial activity of trovafloxacin and five other fluoroquinolonesM P Montanari, M Prenna, M Mingoia, et al.Pageof 308